European Commission clears Otsuka Pharma's Jinarc for kidney disease
Seeking Alpha - at Seeking Alpha - Wed May 27, 9:25AM CDT
Patent Concerns For This Japanese Conglomerate May Represent Buy Opportunity
Robur Investment Resources - at Seeking Alpha - Wed Mar 04, 9:48AM CST
CHMP supports approval of Otsuka kidney disease drug
Seeking Alpha - at Seeking Alpha - Fri Feb 27, 10:19AM CST
'Fast Money' Recap: Next Stop, S&P 2,100?
at The Street - Tue Aug 26, 4:00AM CDT
The trading panel looked at banks and the top buy and sell candidates for right now.
ARWR: 6.68 (+0.07), C: 54.56 (+0.85), BBRY: 7.69 (-0.08), LO: 71.40 (-0.33), XOM: 82.22 (+0.62), BBY: 33.93 (+0.26), IBB: 372.80 (+6.06), QEP: 16.18 (-0.59), XLF: 24.64 (+0.29), KBH: 16.82 (+0.14), X: 18.93 (unch), AMZN: 443.51 (+9.12), HD: 113.10 (+1.72), POT: 28.79 (+0.16), ANN: 48.27 (+0.10), AMGN: 154.10 (+2.79), BAC: 16.70 (+0.22), MO: 51.31 (+0.36), XLU: 42.97 (+0.23), HPQ: 30.65 (+0.26), CELG: 118.84 (+1.97), NFLX: 680.60 (+10.51), BIDU: 187.75 (+0.18), GS: 207.19 (+2.38), ISIS: 53.50 (+0.42), ACHN: 8.68 (+0.14), MRK: 57.95 (+0.57), ICPT: 247.71 (+4.45), MCD: 97.65 (+1.16), NVS: 103.22 (+3.20)